Aclarion Inc. Files Definitive Proxy Statement

TL;DR

Aclarion filed its proxy statement, shareholders vote soon.

AI Summary

Aclarion, Inc. filed a Definitive Proxy Statement (DEF 14A) on August 26, 2024, for the fiscal year ending December 31, 2024. The filing concerns the company's proxy materials, which are used to solicit votes from shareholders for annual meetings. The company's principal executive offices are located at 8181 Arista Place, Suite 100, Broomfield, CO 80021.

Why It Matters

This filing is crucial for shareholders as it outlines the proposals to be voted on at the company's annual meeting, influencing corporate governance and strategic direction.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new financial performance data or significant strategic announcements.

Key Numbers

• 20240923 — Fiscal Year End (The proxy statement is for the period ending this date.)

Key Players & Entities

• Aclarion, Inc. (company) — Registrant
• 20240826 (date) — Filing Date
• 8181 Arista Place, Suite 100, Broomfield, CO 80021 (address) — Principal Executive Offices
• Nocimed, Inc. (company) — Former Company Name

FAQ

Key Financial Figures

• $1.00 — rice of our common stock had been below $1.00 per share for 30 consecutive business d

Filing Documents

• aclarion_def14a.htm (DEF 14A) — 154KB
• 0001683168-24-006029.txt ( ) — 155KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 12 OTHER MATTERS 13 HOUSEHOLDING 13 2023 ANNUAL REPORT 13 i QUESTIONS AND ANSWERS ABOUT THIS PROXY STATEMENT AND VOTING What is a proxy? A proxy is the legal designation of another person to vote the stock you own. That other person is called a proxy. If you designate someone as your proxy in a written document, that document is also called a proxy or a proxy card. By completing, signing and returning the accompanying proxy card, you are designating Brent Ness, Chief Executive Officer, and Jeffrey Thramann, M.D., Executive Chairman, as your proxies for the Special Meeting and you are authorizing Mr. Ness and Dr. Thramann to vote your shares at the Special Meeting as you have instructed on the proxy card. This way, your shares will be voted whether or not you attend the Special Meeting. Even if you plan to attend the Special Meeting, we urge you to vote in one of the ways described below so that your vote will be counted even if you are unable or decide not to attend the Special Meeting. What is a proxy statement? On or about August 26, 2024, we intend to begin mailing to each stockholder of record entitled to vote at the Special Meeting the Notice of Meeting and Proxy Statement. Only stockholders who owned our common stock on August 20, 2024 are entitled to vote at the Special Meeting. Why did you send me this proxy statement? We sent you this proxy statement and the enclosed proxy card because our board of directors is soliciting your proxy to vote at the Special Meeting and any adjournment and postponement thereof. This proxy statement summarizes information related to your vote at the Special Meeting. All stockholders who find it convenient to do so are cordially invited to attend the Special Meeting at the Company’s offices in person. However, you do not need to attend the meeting to vote your shares. Instead, you may simply complete, sign and return the proxy card or vo

View Full Filing

View this DEF 14A filing on SEC EDGAR